NOVONIX Limited (NASDAQ:NVX - Get Free Report) saw a large decline in short interest during the month of February. As of February 15th, there was short interest totalling 503,700 shares, a decline of 31.8% from the January 31st total of 738,800 shares. Based on an average daily volume of 216,900 shares, the short-interest ratio is presently 2.3 days.
NOVONIX Price Performance
NASDAQ:NVX traded down $0.08 during mid-day trading on Thursday, hitting $1.05. The stock had a trading volume of 37,067 shares, compared to its average volume of 177,018. NOVONIX has a twelve month low of $0.97 and a twelve month high of $3.10. The company has a current ratio of 6.15, a quick ratio of 5.94 and a debt-to-equity ratio of 0.44. The company's 50 day simple moving average is $1.56 and its 200 day simple moving average is $1.74.
Institutional Trading of NOVONIX
Hedge funds have recently made changes to their positions in the business. Quinn Opportunity Partners LLC bought a new stake in NOVONIX in the 4th quarter valued at about $99,000. Jackson Hole Capital Partners LLC acquired a new position in shares of NOVONIX during the fourth quarter worth $45,000. Jane Street Group LLC raised its position in NOVONIX by 103.5% in the third quarter. Jane Street Group LLC now owns 34,495 shares of the company's stock valued at $63,000 after purchasing an additional 17,541 shares during the last quarter. Finally, Two Sigma Securities LLC bought a new stake in shares of NOVONIX during the fourth quarter worth about $28,000. 0.06% of the stock is owned by institutional investors and hedge funds.
About NOVONIX
(
Get Free Report)
NOVONIX Limited provides battery materials and development technology for battery manufacturers, materials companies, automotive original equipment manufacturers (OEMs), and consumer electronics manufacturers in North America, Asia, Australia, and Europe. It operates through Battery Materials and Battery Technology segments.
Read More
Before you consider NOVONIX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NOVONIX wasn't on the list.
While NOVONIX currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.